# Combination Chemotherapy and Surgery With or Without G-CSF in Treating Patients With Osteosarcoma

> **NCT00002539** · PHASE3 · COMPLETED · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 214 (actual)

## Conditions studied

- Sarcoma

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** cisplatin
- **DRUG:** doxorubicin hydrochloride
- **PROCEDURE:** conventional surgery

## Key facts

- **NCT ID:** NCT00002539
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1993-08
- **Primary completion:** 2002-10
- **Final completion:** —
- **Target enrollment:** 214 (ACTUAL)
- **Last updated:** 2012-09-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002539, "Combination Chemotherapy and Surgery With or Without G-CSF in Treating Patients With Osteosarcoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00002539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*